CNIO stop cancer
Research & Innovation
Women in Science
Education and career development
CNIO and Society
About the CNIO
What is it we do
With little help from our friends
CNIO Friends Newsletter
La Caixa-CNIO Frontiers Meetings
Women in Science Office Seminar
Activities & Events
Facts & Figures
Contacts & Suggestions
Links of Interest
Career Development Programmes
How to Find Us
CNIO Open doors
CNIO & The City
CNIO Friends welcomes Víctor Frankenstein
Stories to pass the time of day. Stop ignorance
CNIO Friends Newsletter
Journal of Clinical Oncology.
CNIO researchers confirm links between aggressive prostate cancer and hereditary breast cancer
Aggressive prostate cancer, one of the leading causes of cancer deaths in men, is associated with...
Researchers from the CNIO and the Hospital 12 de Octubre make sense out of the chaos of melanoma
Unlike other skin cancers – and without knowing really why – melanoma is one of the most...
The CNIO and Hospital 12 de Octubre find a potential new combination therapy against a rare disease of the bone marrow
Myelofibrosis is a severe and very rare haematological disease for which treatment has only been...
The New England Journal of Medicine (NEJM).
An international clinical trial extends the effectiveness of immunotherapy to more lung cancer patients
The strategy for triggering the patient’s own immune system to attack cancer, immunotherapy, is...
A new methodology predicts the risk of relapse in patients with acute myeloid leukemia
The acute myeloid leukemia (AML) is the most common haematological cancer in adults. With a 5-year...
First blood-based biomarker in response to the treatment of the most aggressive prostate cancer
In collaboration with British and Italian researchers
Journal of Clinical Investigation.
CNIO finds the origin of a type of thrombocytopenia caused by an oncogene
The Cell Division and Cancer Group of the Spanish National Cancer Research Centre (CNIO) has...
Nucleic Acids Research.
An international team led by the CNIO reveals that human genome could contain up to 20% fewer genes
A new study led by the Spanish National Cancer Research Centre (CNIO) reveals that up to 20% of...
CNIO researchers find the first indicators of prognosis for the most aggressive type of breast cancer
The rarest, but also the most aggressive and hard to treat form of breast cancer, is known as triple...
Utilizamos cookies para asegurar que damos la mejor experiencia al usuario en nuestra web.
Política de privacidad